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INTRODUCTION
Diethylenetriaminepentaacetic acid (DTPA) is the current treatment recommended by the U.S. Food and Drug Administration to enhance the elimination of actinides and lanthanides (2) . The recommended therapy is intravenous (i.v.) or nebulized administration of calcium trisodium (Ca-) or zinc trisodium (Zn-) DTPA, which are chelating agents that enhance the elimination of the soluble compounds from the blood, systemic organs and tissues. The DTPA binds with the actinide, causing the resulting chelate [plutonium (Pu-) DTPA] to be rapidly excreted in the urine. For i.v. administration, the recommended daily dose is 30 lmol/ kg À1 animal mass (3) . To study dose dependence, Serandour et al. (1) performed in vitro experiments in rats where plasma samples were withdrawn 1 h after i.v. administration of Pu-citrate. The plasma samples were then incubated at 378C with Ca-DTPA with equivalent doses ranging from 3 3 10 -7 to 3 3 10 -2 mol/kg -1 ( Table 1 ). The plasma samples were then ultrafiltered using a 30,000-nominal-molecularweight membrane by centrifugation at 4,000 rpm for 15 min. For each equivalent dosage of Ca-DTPA, Serandour et al. (1) reported the fraction of the radioactivity that passed through the filter. This fraction, referred to as ultrafiltrability, is assumed to be low-molecular-weight plutonium complexes such as Pu-citrate or Pu-DTPA, but not Putransferrin. Figure 1 shows the influence of equivalent DTPA dosage on the ultrafiltrability of plutonium in plasma of rats [data points obtained from Fig. 1 in ref. (1)]. In Serandour et al. (1) , further quantitative analysis of this data was not done. Here, we model this data using second-order kinetics for several competing reactions, and compare other similar in vitro studies in experimental animals.
An understanding of the second-order kinetics of interactions between plutonium and DTPA will be a useful aid in the development of a physiologically-based model for actinide decorporation therapy, as is being done by the health physics community (6) (7) (8) .
SECOND-ORDER KINETICS
The data shown in Fig. 1 were modeled using secondorder kinetics, assuming the following reactions:
where Pu is plutonium, C is citrate, Tf is transferrin and D is DTPA. The k to the right of each is the reaction rate. The stability constant of PuC is defined by (note capital K):
and similarly, for K PuTf and K PuD . The stability constant gives the equilibrium concentration ratio. For example, for PuC,
In our model, at equilibrium without DTPA, 0.6% (the open square in Fig. 1 
which gives the ratio of the stability constants as:
We require the model to satisfy the constraint given by Eq. (6), so the initial parameter values must satisfy this, and parameter movement must have:
An in vitro study of DTPA kinetics in baboons by Metivier et al. (9) showed that increase in incubation time (up to 2 days) of Ca-DTPA (5 3 10 -4 M) with plutonium in plasma did not significantly improve the removal of plutonium by Ca-DTPA. Two additional data points were therefore obtained for Ca-DTPA equivalent dosage of 3 3 10 -5 mol/kg (6.5 3 10 -4 M) for t ¼ 1 day and 2 days. Similarly, Sueda et al. (10) also reported finding no significant differences in the binding of americium-241 ( 241 Am) with DTPA despite longer reaction times. Based on these studies, in our model fast equilibration was ensured by imposing the requirement that the three decay reaction rates be faster than 300 day À1 (time constant less than 5 min).
Our handling of second-order kinetics has been previously reported elsewhere (11) . The current version of IDode Software (version 1. 5) 2 (discussed in the Appendix) has the ability to fit the model parameters using Markov chain Monte Carlo (MCMC). The numerical solution of the ordinary differential equations representing Eq. (1) was fit to the data of Fig. 1 by varying the five independent rates (k -PuTf is a dependent variable). The solution versus the timedependent data is shown in Fig. 2 
. This is also the source of the solid curve shown in Fig. 1 . Our results were the same when the concentration of citrate was assumed to be equal to that of transferrin.
Probabilistic data interpretation using MCMC was done with log-scale uniform priors on the parameters, extending from a factor of 100 above to a factor of 100 below the initial values. The model in this case has five independent parameters and there are seven data points. In linear fitting theory, this translates to two degrees of freedom and an expectation that the parameters would be determined by the data. This is not a linear problem, and in fact, the posterior variation of the reaction rates was found to extend over the full range of the prior, i.e., the parameter values were not found to be restricted by the measurement data. However, the ratio of the stability constants is fairly well determined by the data, as shown in Fig. 3 .
DISCUSSION AND CONCLUSION
The equilibrium concentration ratio [PuD]/[PuTf] can be determined using:
At the recommended DTPA dosage, the ratio of DTPA to Tf concentration is approximately 10 ( However, another approach is to not model the actual detailed chemistry taking place but instead to model the data with a single ''effective'' DTPA-actinide reaction,
which allows simple modeling of the DTPA-actinide kinetics using experimentally-derived effective reaction rates. Without competing reactions, the curve in Fig. 1 (dotted curve) does not have a sigmoidal shape, but is able to fit the measured data by excluding the data point for the lowest Ca-DTPA dosage ( P v 2 /nData ¼ 0.81, nData ¼ 5). Plutonium ultrafiltrability of 50% is achieved at a DTPA concentration of approximately 2 3 10 -2 M in rats (Fig. 1) . Metivier et al. (9) found that a concentration of approximately 10 -3 M was required to obtain 50% removal of Pu-TBP from plasma in baboons. Sueda et al. (10) reported that different concentrations of DTPA are required in different species to obtain same percentage of binding of 241 Am in different species (Table 2 ). These differences may be due to the differences in concentrations of various competing ligands in plasma of different species. Seuda et al. (10) indicated that the collective effects of various ligands and metals in plasma may be responsible for species-specific differences observed. It is also important to note the differences between the binding of plutonium and americium with DTPA. The concentration of DTPA required to bind 50% of plutonium in plasma in rats is several orders of magnitude greater than that required to bind the same amount of americium. This is possibly because Am(III)-Tf complex is not as stable as that of plutonium, and thus Am(III) may be associated with other proteins such as albumin (12) .
As shown in Fig. 1 , only when DTPA dosage is three orders of magnitude greater than the recommended dosage, is 100% of plutonium apparently bound to DTPA. Nevertheless, caution should be applied when extrapolating information such as this for application to decorporation biokinetic models in humans. As discussed, species-specific differences must be taken into account. As Sueda et al. (10) indicated, DTPA is more efficient in human plasma than in rats or beagles. In addition, it should be noted that these results are specific to chemical reactions with DTPA occurring in plasma and not reactions occurring elsewhere in the body. The in vitro studies cannot simulate, to a complete extent, the complexities encountered in vivo, such as translocation and excretion of actinides, selective cell membranes or the presence of other competitive binding ions such as iron or zinc (1, 13).
APPENDIX The IDode Computer Program
The calculations utilized the IDode computer program version 1.5 (Internal Dosimetry code using numerical solution of the Ordinary Differential Equations defining the model). IDode makes use of the methods discussed by Miller (14) .
The units used by IDode are: time in days and quantity of material in program units (IDodeUnit). For radioactive materials in the decay chain IDodeUnits are proportional to the nuclide activity with conversion to Bq using the program constant BqPerIDodeUnit. For nonradioactive material, IDodeUnits are proportional to the number of molecules in a reference volume. For radioactive materials (for the mother of the chain) and for nonradioactive materials, IDodeUnits are proportional to the number of molecules, so that they can be directly compared. For this problem at the highest DTPA concentration, the initial amounts of material in IDodeUnits are: [ 
